#pharmaceos — Public Fediverse posts

Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B—Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset —9 top biopharma CEO-to-employee pay gaps --http://bit.ly/w28kSd #biogen #mergersandacquisitions #boehringeringelheim #cardiovasculardisease #pharmaceos #executivecompensation #paygap #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B—Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset —9 top biopharma CEO-to-employee pay gaps --http://bit.ly/w28kSd #biogen #mergersandacquisitions #boehringeringelheim #cardiovasculardisease #pharmaceos #executivecompensation #paygap #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B—Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset —9 top biopharma CEO-to-employee pay gaps --http://bit.ly/w28kSd #biogen #mergersandacquisitions #boehringeringelheim #cardiovasculardisease #pharmaceos #executivecompensation #paygap #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B—Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset —9 top biopharma CEO-to-employee pay gaps --http://bit.ly/w28kSd #biogen #mergersandacquisitions #boehringeringelheim #cardiovasculardisease #pharmaceos #executivecompensation #paygap #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal—In his final full year as AbbVie's CEO, Richard Gonzalez collects $25.7M in total pay—Bayer cues up filings for rival to Astellas’ menopause drug--http://bit.ly/w28kSd #astrazeneca #mergersandacquisitions #radiopharmaceuticals #pharmaceos #executivecompensation #abbvie #bayer #hotflashes #menopause #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal—In his final full year as AbbVie's CEO, Richard Gonzalez collects $25.7M in total pay—Bayer cues up filings for rival to Astellas’ menopause drug--http://bit.ly/w28kSd #astrazeneca #mergersandacquisitions #radiopharmaceuticals #pharmaceos #executivecompensation #abbvie #bayer #hotflashes #menopause #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal—In his final full year as AbbVie's CEO, Richard Gonzalez collects $25.7M in total pay—Bayer cues up filings for rival to Astellas’ menopause drug--http://bit.ly/w28kSd #astrazeneca #mergersandacquisitions #radiopharmaceuticals #pharmaceos #executivecompensation #abbvie #bayer #hotflashes #menopause #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Bernie Sanders Has a Plan to Make Big Pharma’s Greedheads Squirm

https://newrepublic.com/article/178663/bernie-sanders-pharma-ceos-pricing

#BernieSandersPlan #BigPharmaGreedheads #PharmaCEOs #Pricing #Healthcare #DrugAffordability #Politics #News

Bernie Sanders Has a Plan to Make Big Pharma’s Greedheads Squirm

https://newrepublic.com/article/178663/bernie-sanders-pharma-ceos-pricing

#BernieSandersPlan #BigPharmaGreedheads #PharmaCEOs #Pricing #Healthcare #DrugAffordability #Politics #News

Bernie Sanders Has a Plan to Make Big Pharma’s Greedheads Squirm

https://newrepublic.com/article/178663/bernie-sanders-pharma-ceos-pricing

#BernieSandersPlan #BigPharmaGreedheads #PharmaCEOs #Pricing #Healthcare #DrugAffordability #Politics #News

Bernie Sanders Has a Plan to Make Big Pharma’s Greedheads Squirm

https://newrepublic.com/article/178663/bernie-sanders-pharma-ceos-pricing

#BernieSandersPlan #BigPharmaGreedheads #PharmaCEOs #Pricing #Healthcare #DrugAffordability #Politics #News

Bernie Sanders Has a Plan to Make Big Pharma’s Greedheads Squirm

https://newrepublic.com/article/178663/bernie-sanders-pharma-ceos-pricing

#BernieSandersPlan #BigPharmaGreedheads #PharmaCEOs #Pricing #Healthcare #DrugAffordability #Politics #News

Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss-- 5 of the best paid biopharma CEOs --One dose of Lilly’s siRNA drug cuts Lp(a) for a year -- See more on our front page news http://bit.ly/w28kSd #novonordisk #wegovy #heartdisease #clinicaltrials #executivepay #pharmaceos #ceos #aha #elililly #sirna #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss-- 5 of the best paid biopharma CEOs --One dose of Lilly’s siRNA drug cuts Lp(a) for a year -- See more on our front page news http://bit.ly/w28kSd #novonordisk #wegovy #heartdisease #clinicaltrials #executivepay #pharmaceos #ceos #aha #elililly #sirna #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches-- Bayer CEO Anderson says 'radical realignment' is underway --Gilead tumbles after unpredictable element drove its 3Q beat -- See more on our front page news http://bit.ly/w28kSd #biogen #pharmaceos #bayer #layoffs #gileadsciences #earnings #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches-- Bayer CEO Anderson says 'radical realignment' is underway --Gilead tumbles after unpredictable element drove its 3Q beat -- See more on our front page news http://bit.ly/w28kSd #biogen #pharmaceos #bayer #layoffs #gileadsciences #earnings #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations-- Sen. Bernie Sanders moves toward another hearing with pharma CEOs --Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March -- See more on our front page news http://bit.ly/w28kSd #vertexpharmaceuticals #genetherapy #senate #drugpricing #pharmaceos #berniesanders #eisai #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations-- Sen. Bernie Sanders moves toward another hearing with pharma CEOs --Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March -- See more on our front page news http://bit.ly/w28kSd #vertexpharmaceuticals #genetherapy #senate #drugpricing #pharmaceos #berniesanders #eisai #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt—AI policymaking needs more voices from healthcare -- Lilly’s donanemab flaunts strong clinical profile, ready to compete with Leqembi -- See more on our front page news http://bit.ly/w28kSd #amarin #layoffs #restructuring #pharmaceos #ai #policy #healthcare #artificialintelligence #alzheimers #elililly #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt—AI policymaking needs more voices from healthcare -- Lilly’s donanemab flaunts strong clinical profile, ready to compete with Leqembi -- See more on our front page news http://bit.ly/w28kSd #amarin #layoffs #restructuring #pharmaceos #ai #policy #healthcare #artificialintelligence #alzheimers #elililly #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Diabetes tech: a catalyst rich sector with a dazzling future — Lundbeck replaces retiring CEO Deborah Dunsire with UCB exec after breaking sales record --Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase 3 and new indications -- See more on our front page news http://bit.ly/w28kSd #diabetes #medtech #ada #lundbeck #pharmaceos #sanofi #eczema #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Diabetes tech: a catalyst rich sector with a dazzling future — Lundbeck replaces retiring CEO Deborah Dunsire with UCB exec after breaking sales record --Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase 3 and new indications -- See more on our front page news http://bit.ly/w28kSd #diabetes #medtech #ada #lundbeck #pharmaceos #sanofi #eczema #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Merck secures Bridion patent protection through January 2026— Eli Lilly CEO says Medicare price negotiations could harm drug development -- Eli Lilly’s Mounjaro likely to become ‘leading therapy’ for obesity and type 2 diabetes -- See more on our front page news http://bit.ly/w28kSd #merck #patents #elililly #pharmaceos #medicare #drugpricing #mounjaro #type2diabetes #obesity #drugdevelopment #inflationreductionact #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Merck secures Bridion patent protection through January 2026— Eli Lilly CEO says Medicare price negotiations could harm drug development -- Eli Lilly’s Mounjaro likely to become ‘leading therapy’ for obesity and type 2 diabetes -- See more on our front page news http://bit.ly/w28kSd #merck #patents #elililly #pharmaceos #medicare #drugpricing #mounjaro #type2diabetes #obesity #drugdevelopment #inflationreductionact #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices— After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints --Zuckerberg cash helping to propel Chicago's biotech ambitions -- See more on our front page news http://bit.ly/w28kSd #bio #bio23 #biosimilars #drugpricing #merck #inflationreductionact #pharmaceos #zuckerberg #chicago #biotechhub #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices— After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints --Zuckerberg cash helping to propel Chicago's biotech ambitions -- See more on our front page news http://bit.ly/w28kSd #bio #bio23 #biosimilars #drugpricing #merck #inflationreductionact #pharmaceos #zuckerberg #chicago #biotechhub #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Moderna's gene therapy expansion picks up pace with $76M upfront Generation Bio collab— Disgraced former Seagen CEO tapped to lead MorphImmune less than a year after domestic assault arrest— Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD -- See more on our front page news http://bit.ly/w28kSd #moderna #gentherapy #pharmaceos #sanofi #regeneneron #copd #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AbbVie CEO Gonzalez scored $26M in 2022 pay as cash cow Humira neared patent cliff— What ancient art form has inspired many technological advances for medical devices? — FDA delays review of BioMarin's hemophilia gene therapy after data update-- See more on our front page news http://bit.ly/w28kSd #abbvie #pharmaceos #patents #devices #meddevice #medtech #productdesign #hemophilia #biomarin #genetherapy #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma